Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
Science · 21.06.2024 · 384 (6702)
DOI: 10.1126/science.adh5548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 21.06.2024. Verfasst von Andrew E Whiteley und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, Breast Neoplasms, Integrin alpha6, Meningeal Neoplasms. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM by abluminal migration along blood vessels that connect vertebral or calvarial bone marrow and meninges, bypassing the blood-brain barrier. This process is dependent on BCC engagement with vascular basement membrane laminin through expression of the neuronal pathfinding molecule integrin α6. Once in the LM, BCCs colocalize with perivascular meningeal macrophages and induce their expression of the prosurvival neurotrophin glial-derived neurotrophic factor (GDNF). Intrathecal GDNF blockade, macrophage-specific GDNF ablation, or deletion of the GDNF receptor neural cell adhesion molecule (NCAM) from BCCs inhibits breast cancer growth within the LM. These data suggest integrin α6 and the GDNF signaling axis as new therapeutic targets against breast cancer LM metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA.
- Department of Neurosurgery, Duke University, Durham, NC 27710, USA.
- Department of Pathology, Duke University, Durham, NC 27710, USA.
ORCID-Profile: Andrew E Whiteley, Danhui Ma, Lihua Wang, Seok-Yeong Yu, Claire Yin, Brennan G Simon, Katie R Xu, Kathleen A Marsh, Maegan L Brockman, Tatiana M Prioleau, Katherine I Zhou, William R Jeck, Chad M McCall, Jadee L Neff, Dorothy A Sipkins
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NCI NIH HHS
Zitieren
APA
Whiteley, A. E., Ma, D., Wang, L., Yu, S. Y., Yin, C., Price, T. T., Simon, B. G., Xu, K. R., Marsh, K. A., Brockman, M. L., Prioleau, T. M., Zhou, K. I., Cui, X., Fecci, P. E., Jeck, W. R., McCall, C. M., Neff, J. L., & Sipkins, D. A. (2024). Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science, 384(6702). https://doi.org/10.1126/science.adh5548
Vancouver
Whiteley AE, Ma D, Wang L, Yu SY, Yin C, Price TT, et al. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 2024;384(6702). doi:10.1126/science.adh5548
BibTeX
@article{Whiteley2024,
author = {Whiteley, Andrew E and Ma, Danhui and Wang, Lihua and Yu, Seok-Yeong and Yin, Claire and Price, Trevor T and Simon, Brennan G and Xu, Katie R and Marsh, Kathleen A and Brockman, Maegan L and Prioleau, Tatiana M and Zhou, Katherine I and Cui, Xiuyu and Fecci, Peter E and Jeck, William R and McCall, Chad M and Neff, Jadee L and Sipkins, Dorothy A},
title = {Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis},
journal = {Science},
year = {2024},
volume = {384},
number = {6702},
doi = {10.1126/science.adh5548}
}
EUVIMED